EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens

Lawrence A Leiter, Taruja Karmarkar, Lori D Bash, Jason Exter, Jordana K Schmier, Sayeli P Jayade, Kyle C Roney, Ross J Simpson, Seth J Baum

American Journal of Preventive Cardiology · 2026-02 · 25 · 101386

DOI: 10.1016/j.ajpc.2025.101386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-02. Verfasst von Lawrence A Leiter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Sharp and Dohme United Kingdom, Merck & Co Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Improving care of patients with hyperlipidemia requires an understanding of the barriers physicians perceive in prescribing low-density lipoprotein cholesterol (LDL-C)-lowering therapies. This study explores physicians' perceptions of time and resource burdens, identify perceived patient adherence barriers, and examine factors influencing physicians' decision-making in LDL-C management.

Methods

This is a non-interventional, cross-sectional, online survey of US-based primary care practitioners (PCP) and cardiologists who recommended or provided lipid-lowering therapy (LLT) to ≥50 adults per month, practiced for ≥2 years, and completed the survey in English. The survey comprised multiple-choice, constant sum, and numerical questions about physician decision-making, patient management, and perceptions of patient attitudes/behaviors regarding LDL-C management. Descriptive univariate analyses were conducted.

Results

200 PCPs and 200 cardiologists completed the survey. Most physicians reported prescribing lipid-lowering therapy (LLT) and that patients declined injectable proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i). They attributed this refusal to cost/insurance, fear/discomfort taking injections, and a preference for oral therapies. Physicians viewed patients with a history of ASCVD, with LLT experience, and those with greater understanding of ASCVD risk to have higher LLT adherence compared to those without. Most physicians spent a median of 10 min in shared decision-making conversations, regardless of therapies they prescribed. They reported needing longer to instruct patients during adherence counseling for PCSK9is than for oral therapies.

Conclusions

Our findings suggest patient, clinician, and system barriers may all hinder LDL-C management and adherence. A greater understanding of the association between perceived barriers and real-world behaviors will help optimize lipid management.

Schlagwörter

Stichwörter der Autor:innen

Cross-sectional surveyLow-density lipoprotein cholesterol managementPhysician perspectivesResource burden

Autor:innen und Institutionen

  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Merck & Co., Inc., Rahway, NJ, USA.
  • OPEN Health, 4350 East West Highway, Suite 1100, Bethesda, MD, USA.
  • Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Flourish Research, Apex, NC; Charles E. Schmidt College of Medicine, Boca Raton, FL, USA.

Förderung

  • Merck Sharp and Dohme United Kingdom
  • Merck & Co Inc

Zitieren

APA

Leiter, L. A., Karmarkar, T., Bash, L. D., Exter, J., Schmier, J. K., Jayade, S. P., Roney, K. C., Simpson, R. J., & Baum, S. J. (2026). Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens. American Journal of Preventive Cardiology, 25, 101386. https://doi.org/10.1016/j.ajpc.2025.101386

Vancouver

Leiter LA, Karmarkar T, Bash LD, Exter J, Schmier JK, Jayade SP, et al. Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens. American Journal of Preventive Cardiology. 2026;25:101386. doi:10.1016/j.ajpc.2025.101386

BibTeX
@article{Leiter2026,
  author = {Leiter, Lawrence A and Karmarkar, Taruja and Bash, Lori D and Exter, Jason and Schmier, Jordana K and Jayade, Sayeli P and Roney, Kyle C and Simpson, Ross J and Baum, Seth J},
  title = {Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  volume = {25},
  pages = {101386},
  doi = {10.1016/j.ajpc.2025.101386}
}
Kostenlos starten →